1. Home
  2. BGLC vs ULY Comparison

BGLC vs ULY Comparison

Compare BGLC & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • ULY
  • Stock Information
  • Founded
  • BGLC 2017
  • ULY 2013
  • Country
  • BGLC Malaysia
  • ULY United States
  • Employees
  • BGLC N/A
  • ULY N/A
  • Industry
  • BGLC Medical Specialities
  • ULY
  • Sector
  • BGLC Health Care
  • ULY
  • Exchange
  • BGLC Nasdaq
  • ULY Nasdaq
  • Market Cap
  • BGLC 5.8M
  • ULY 6.7M
  • IPO Year
  • BGLC N/A
  • ULY N/A
  • Fundamental
  • Price
  • BGLC $0.35
  • ULY $0.45
  • Analyst Decision
  • BGLC
  • ULY Strong Buy
  • Analyst Count
  • BGLC 0
  • ULY 1
  • Target Price
  • BGLC N/A
  • ULY $1.50
  • AVG Volume (30 Days)
  • BGLC 177.5K
  • ULY 42.7K
  • Earning Date
  • BGLC 03-04-2025
  • ULY 03-13-2025
  • Dividend Yield
  • BGLC N/A
  • ULY N/A
  • EPS Growth
  • BGLC N/A
  • ULY N/A
  • EPS
  • BGLC N/A
  • ULY 7.18
  • Revenue
  • BGLC $9,259,858.00
  • ULY $155,926,000.00
  • Revenue This Year
  • BGLC N/A
  • ULY N/A
  • Revenue Next Year
  • BGLC N/A
  • ULY $4.29
  • P/E Ratio
  • BGLC N/A
  • ULY $0.06
  • Revenue Growth
  • BGLC N/A
  • ULY N/A
  • 52 Week Low
  • BGLC $0.21
  • ULY $0.41
  • 52 Week High
  • BGLC $1.20
  • ULY $3.45
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 46.44
  • ULY 40.36
  • Support Level
  • BGLC $0.33
  • ULY $0.47
  • Resistance Level
  • BGLC $0.40
  • ULY $0.55
  • Average True Range (ATR)
  • BGLC 0.02
  • ULY 0.04
  • MACD
  • BGLC -0.01
  • ULY -0.00
  • Stochastic Oscillator
  • BGLC 23.07
  • ULY 0.00

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and lead to long wait times. Urgently offers an innovative alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

Share on Social Networks: